Capobianco, Marco, Department of Neurology, Regionale Multiple Sclerosis Centre (CReSM), University-hospital San Luigi Gonzaga, Orbassano, Italy

• Vol 20, No 1 (2019) - Original research
  The Value and Sustainability of Ocrelizumab in Relapsing Multiple Sclerosis: A Cost-Effectiveness and Budget Impact Analysis
  Abstract  HTML  PDF